News
Important Only
Stocks
US FDA approves SpringWorks' genetic disorder drug
Adds background in paragraphs 4-6 and 12, details on drug in paragraph 7,10, company executive comment in paragraph 8 Feb 11 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' SWTX.O drug to treat a type of rare genetic disorder, which ...Reuters
Tue, Feb 11
Stocks
Assurant Inc reports results for the quarter ended December 31 - Earnings Summary
Assurant Inc AIZ.N reported quarterly adjusted earnings of $4.79 per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $4.58. The mean expectation of eight analysts for the quarter was for earnings of $4.13 per share. Wall Street exp...Reuters
Tue, Feb 11
Stocks
Angi Inc reports results for the quarter ended December 31 - Earnings Summary
Angi Inc ANGI.OQ reported quarterly breakeven results per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -1 cents. The mean expectation of eight analysts for the quarter was for breakeven results per share. Wall Street expected re...Reuters
Tue, Feb 11
Other
BRIEF-Confluent Announces Strategic Partnership With Jio Platforms Limited To Accelerate India’S Development Of Genai And Next-Gen Applications With Data Streams Through Jio Cloud Services
Confluent Inc CFLT.O:CONFLUENT ANNOUNCES STRATEGIC PARTNERSHIP WITH JIO PLATFORMS LIMITED TO ACCELERATE INDIA’S DEVELOPMENT OF GENAI AND NEXT-GEN APPLICATIONS WITH DATA STREAMS THROUGH JIO CLOUD SERVICESSource text: ID:nBwc8k6kKaFurther company coverage: CFLT.OReuters
Tue, Feb 11
Other
BRIEF-FMC Corp Enters Amendment No. 4 To Credit Agreement
Feb 11 (Reuters) - FMC Corp FMC.N:FMC CORP - ENTERS AMENDMENT NO. 4 TO CREDIT AGREEMENTFMC CORP - EXTENDS CREDIT FACILITY TERMINATION DATE TO JUNE 17, 2028FMC CORP - CREDIT AGREEMENT INCLUDES $2 BILLION REVOLVING CREDIT FACILITYSource text: [ID:n0000037785-25-000015]Further company coverage: FMC.NReuters
Tue, Feb 11
Other
BRIEF-Forrester Research Inc- QTRLY Adjusted EPS $0.36
Forrester Research Inc FORR.O:QTRLY ADJUSTED EPS $0.36OUTLOOK FY TOTAL REVENUES OF ABOUT $400.0 MILLION TO $415.0 MILLION, OR A DECLINE OF 7.5% TO 4.0% VERSUS PRIOR YEAROUTLOOK FY ADJUSTED DILUTED EARNINGS PER SHARE OF APPROXIMATELY $1.20 TO $1.35FY2025 EARNINGS PER SHARE VIEW $1.66, REVENUE VIEW $4...Reuters
Tue, Feb 11
Other
BRIEF-Hexcel Corp Files For Offering Of $300 Million 5.875% Senior Notes Due 2035 -SEC Filing
Feb 11 (Reuters) - Hexcel Corp HXL.N:HEXCEL CORP FILES FOR OFFERING OF $300 MILLION 5.875% SENIOR NOTES DUE 2035 -SEC FILINGSource text: [ID:n0001140361-25-003864]Further company coverage: HXL.NReuters
Tue, Feb 11
Other
BRIEF-Ivanhoe Electric Files Of Offering Of Units For Gross Proceeds Of $50 Mln
Feb 11 (Reuters) - Ivanhoe Electric Inc IE.TO:IVANHOE ELECTRIC FILES OF OFFERING OF UNITS FOR GROSS PROCEEDS OF $50 MILLION- SEC FILINGSource text: [ID:n0001104659-25-011532]Further company coverage: IE.TOReuters
Tue, Feb 11
Other
BRIEF-State Of Israel Files Pricing Term Sheet Related To Offering Of Us$2.5 Billion 5.375% Bonds Due 2030, Us$2.5 Billion 5.625% Bonds Due 2035 -SEC Filing
STATE OF ISRAEL FILES PRICING TERM SHEET RELATED TO OFFERING OF US$2.5 BILLION 5.375% BONDS DUE 2030, US$2.5 BILLION 5.625% BONDS DUE 2035 -SEC FILINGSource text: [ID:n0001104659-25-011566]Further company coverage: [ ]Reuters
Tue, Feb 11
Other
BRIEF-Springworks Therapeutics Announces FDA Approval Of Gomekli (Mirdametinib) For Treatment Of Adult And Pediatric Patients With NF1-PN
Feb 11 (Reuters) - SpringWorks Therapeutics Inc SWTX.O:SPRINGWORKS THERAPEUTICS ANNOUNCES FDA APPROVAL OF GOMEKLI™ (MIRDAMETINIB) FOR THE TREATMENT OF ADULT AND PEDIATRIC PATIENTS WITH NF1-PNSource text: ID:nGNX2JBPk7Further company coverage: SWTX.OReuters
Tue, Feb 11
Other
BRIEF-Toromont Industries Ltd - Increases Quarterly Dividend By 8.3% To 52 Cents Per Share
Toromont Industries Ltd TIH.TO:TOROMONT INDUSTRIES LTD - INCREASES QUARTERLY DIVIDEND BY 8.3% TO 52 CENTS PER SHARETOROMONT INDUSTRIES LTD: QTRLY BASIC EARNINGS PER SHARE CAD $1.91Source text: ID:nCNW8bh9vaFurther company coverage: TIH.TOReuters
Tue, Feb 11
Other
BRIEF-Flowers Foods, Inc. Prices $500 Million Of 5.750% Senior Notes Due 2035 And $300 Million Of 6.200% Senior Notes Due 2055
Flowers Foods Inc FLO.N:FLOWERS FOODS, INC. PRICES $500 MILLION OF 5.750% SENIOR NOTES DUE 2035 AND $300 MILLION OF 6.200% SENIOR NOTES DUE 2055Source text: ID:nPn1LMYhGaFurther company coverage: FLO.NReuters
Tue, Feb 11
Other
BRIEF-Equity Bancshares Co Enters Into Eighth Amendment To Loan Agreement With Servisfirst Bank
Feb 11 (Reuters) - Equity Bancshares Inc EQBK.N:EQUITY BANCSHARES INC - ON FEB 10, CO ENTERS INTO EIGHTH AMENDMENT TO LOAN AGREEMENT WITH SERVISFIRST BANKEQUITY BANCSHARES INC - MATURITY DATE OF LOAN AGREEMENT EXTENDED TO FEBRUARY 10, 2026Source text: [ID:n0000950170-25-017986]Further company covera...Reuters
Tue, Feb 11
Other
BRIEF-Anaptys To Announce Top-Line Data From Phase 2B Trial Of Rosnilimab, A PD-1 Depleter And Agonist, In Rheumatoid Arthritis
Feb 11 (Reuters) - AnaptysBio Inc ANAB.O:ANAPTYS TO ANNOUNCE TOP-LINE DATA FROM PHASE 2B TRIAL OF ROSNILIMAB, A PD-1 DEPLETER AND AGONIST, IN RHEUMATOID ARTHRITIS ON FEB. 12, 2025Source text: ID:nGNX2ssLQQFurther company coverage: ANAB.OReuters
Tue, Feb 11
Stocks
Acadia Realty Trust reports results for the quarter ended December 31 - Earnings Summary
Acadia Realty Trust AKR.N reported quarterly adjusted earnings of 8 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -2 cents. The mean expectation of five analysts for the quarter was for earnings of 9 cents per share. Wa...Reuters
Tue, Feb 11
Other
BRIEF-Lifeway Foods Expects To Realize $5 Million Net Gain From Sale Of Simple Foods To Flowers Foods
Feb 11 (Reuters) - Lifeway Foods Inc LWAY.O:LIFEWAY FOODS EXPECTS TO REALIZE $5 MILLION NET GAIN FROM SALE OF SIMPLE FOODS TO FLOWERS FOODSSource text: ID:nPn72DLFzaFurther company coverage: LWAY.OReuters
Tue, Feb 11
